- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.04. | Dividendenbekanntmachungen (24.04.2025) | 12.414 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0127 EUR ALPHA GROUP INTERNATIONAL PLC GB00BF1TM596 0,14 GBP 0,1638 EUR AQ GROUP AB SE0022062196 1... ► Artikel lesen | |
| 22.04. | Getinge AB: Resolutions at Getinge's Annual General Meeting April 22, 2025 | 225 | GlobeNewswire (Europe) | Press Release
Gothenburg, Sweden on April 22, 2025
Getinge AB (publ)'s Annual General Meeting ("AGM") was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the... ► Artikel lesen | |
| 22.04. | Getinge AB: Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward | 222 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on April 22, 2025
"We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias... ► Artikel lesen | |
| 22.04. | Getinge AB Non-GAAP EPS of €0.46, revenue of €520.1M; initiates FY25 outlook | 3 | Seeking Alpha | ||
| 08.04. | Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call | 4 | Cision News | ||
| 27.03. | Getinge publishes Annual Report for 2024 | 295 | PR Newswire | GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes... ► Artikel lesen | |
| 24.03. | Federal court revives Getinge heart pump patent suit against J&J's Abiomed | 8 | MassDevice | ||
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 20.03. | Embracing Getinge's purpose | 3 | Cision News | ||
| 18.03. | Getinge introduces Neural Pressure Support for the Servo-u ventilator system | 11 | Cision News | ||
| 13.03. | NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL) | 4 | Cision News | ||
| 11.03. | Getinge's Nomination Committee proposes Ulrika Dellby as new Board member | 4 | Cision News | ||
| 27.02. | Getinge's new DPTE[®]-FLEX Alpha port enables gloveless component transfer, minimizing human intervention and contamination risks in pharmaceutical production | 5 | Cision News | ||
| 30.01. | Getinge to phase out its surgical perfusion business | 31 | MassDevice | ||
| 28.01. | Getinge shares surge on strong Q4, beats expectations across the board | 6 | Investing.com | ||
| 28.01. | Getinge AB Non-GAAP EPS of SEK 5.28, revenue of SEK 11.07B; initiates FY25 outlook | 4 | Seeking Alpha | ||
| 28.01. | Getinge AB: Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins | 876 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on January 28, 2025
"In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly,... ► Artikel lesen | |
| 14.01. | Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call | 20 | Cision News | ||
| 09.01. | Getinge to be Cincinnati Children's Anesthesia Fleet Provider | 4 | Cision News | ||
| 19.12.24 | Getinge and 908 Devices partner to enhance bioreactor capabilities for continuous monitoring of key cell culture parameters | 6 | Cision News | ||
| 18.12.24 | GETINGE: Healthmark - a legacy of innovation in infection control | 5 | Cision News |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 50,32 | -0,40 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 41,50 Euro auf "Underweight" belassen. Die Anleger warteten auf neue Mittelfristziele und Neuigkeiten... ► Artikel lesen | |
| ESSILORLUXOTTICA | 249,00 | -0,04 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für EssilorLuxottica mit einem Kursziel von 300 Euro auf "Outperform" belassen. Analyst Piral Dadhania rechnet in dem am Dienstag... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 158,10 | -0,28 % | Align Technology-Aktie heute am Aktienmarkt kaum gefragt: Kurs fällt (154,1425 €) | Die Align Technology-Aktie notiert heute ein wenig leichter. Zuletzt zahlten Investoren für die Aktie 174,85 US-Dollar. Das Wertpapier von Align Technology verzeichnet aktuell einen Abschlag von 4,24... ► Artikel lesen | |
| INMODE | 12,510 | +0,72 % | InMode Ltd.: InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 | YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent... ► Artikel lesen | |
| ELEVANCE HEALTH | 344,70 | -0,14 % | How Is Elevance Health's Stock Performance Compared to Other Healthcare Services Stock? | ||
| TENET | 149,00 | +1,36 % | TENET HEALTHCARE CORP - 8-K, Current Report | ||
| BONESUPPORT | 24,980 | +0,08 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
| ARJO | 2,886 | -0,62 % | Dividendenbekanntmachungen (30.04.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AG MORTGAGE INVESTMENT TRUST INC US0012285013 0,2 USD EUR ALLIED PROPERTIES REAL ESTATE INVESTMENT ... CA0194561027 0,15 CAD 0... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 17,500 | +5,42 % | AMN Healthcare Services Inc: AMN Healthcare Announces First Quarter 2025 Results | Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator... ► Artikel lesen | |
| OSSDSIGN | 1,270 | -1,55 % | Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign raises approximately SEK 158 million, announces an updated strategy and revises financial targets | ||
| CHECK-CAP | 0,700 | -0,71 % | MediPharm Labs Corp.: MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd. | TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm", the "Company", or "we"), a pharmaceutical company specialized in precision-based cannabinoids, today provided... ► Artikel lesen | |
| ALPHATEC | 11,000 | +4,27 % | Alphatec Holdings, Inc. Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook | CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 18,800 | -1,57 % | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Ongoing Disclosure Notice - Ordinary Shares | ||
| CROSS COUNTRY HEALTHCARE | 11,300 | 0,00 % | CROSS COUNTRY HEALTHCARE INC - 10-Q, Quarterly Report | ||
| STEREOTAXIS | 1,990 | +1,53 % | Stereotaxis, Inc.: Stereotaxis Reports 2025 First Quarter Financial Results | ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results... ► Artikel lesen |
Das Unternehmen GETINGE AB ADR kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 16,900 Euro und damit +1,81 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.